Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.55 USD | +0.82% | -5.60% | -19.09% |
Apr. 09 | Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing | MT |
Apr. 05 | Sector Update: Health Care Stocks Rise Friday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.09% | 7.02B | |
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics Incorporated : Morgan Stanley Adjusts Price Target on Cytokinetics to $45 From $38, Maintains Overweight Rating